ReShape Lifesciences Inc (RSLS) concluded trading on Wednesday at a closing price of $0.45, with 73.96 million shares of worth about $33.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -92.04% during that period and on April 03, 2025 the price saw a loss of about -71.70%. Currently the company’s common shares owned by public are about 3.31M shares, out of which, 2.71M shares are available for trading.
Stock saw a price change of -4.72% in past 5 days and over the past one month there was a price change of -55.45%. Year-to-date (YTD), RSLS shares are showing a performance of -89.91% which decreased to -95.23% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.34 but also hit the highest price of $29.00 during that period. The average intraday trading volume for ReShape Lifesciences Inc shares is 5.39 million. The stock is currently trading -32.61% below its 20-day simple moving average (SMA20), while that difference is down -74.80% for SMA50 and it goes to -92.79% lower than SMA200.
ReShape Lifesciences Inc (NASDAQ: RSLS) currently have 3.31M outstanding shares and institutions hold larger chunk of about 1.01% of that.
The stock has a current market capitalization of $1.49M and its 3Y-monthly beta is at 1.27. It has posted earnings per share of -$16.40 in the same period. It has Quick Ratio of 0.60 while making debt-to-equity ratio of 0.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RSLS, volatility over the week remained 85.37% while standing at 30.32% over the month.
